1. Home
  2. EXAS vs SWKS Comparison

EXAS vs SWKS Comparison

Compare EXAS & SWKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXAS
  • SWKS
  • Stock Information
  • Founded
  • EXAS 1995
  • SWKS 1962
  • Country
  • EXAS United States
  • SWKS United States
  • Employees
  • EXAS N/A
  • SWKS N/A
  • Industry
  • EXAS Medical Specialities
  • SWKS Semiconductors
  • Sector
  • EXAS Health Care
  • SWKS Technology
  • Exchange
  • EXAS Nasdaq
  • SWKS Nasdaq
  • Market Cap
  • EXAS 10.6B
  • SWKS 11.4B
  • IPO Year
  • EXAS N/A
  • SWKS 1968
  • Fundamental
  • Price
  • EXAS $57.01
  • SWKS $76.45
  • Analyst Decision
  • EXAS Strong Buy
  • SWKS Hold
  • Analyst Count
  • EXAS 21
  • SWKS 18
  • Target Price
  • EXAS $67.86
  • SWKS $72.69
  • AVG Volume (30 Days)
  • EXAS 2.3M
  • SWKS 2.7M
  • Earning Date
  • EXAS 11-04-2025
  • SWKS 11-11-2025
  • Dividend Yield
  • EXAS N/A
  • SWKS 3.63%
  • EPS Growth
  • EXAS N/A
  • SWKS N/A
  • EPS
  • EXAS N/A
  • SWKS 2.50
  • Revenue
  • EXAS $2,939,949,000.00
  • SWKS $4,011,700,000.00
  • Revenue This Year
  • EXAS $16.68
  • SWKS N/A
  • Revenue Next Year
  • EXAS $12.08
  • SWKS N/A
  • P/E Ratio
  • EXAS N/A
  • SWKS $30.80
  • Revenue Growth
  • EXAS 12.55
  • SWKS N/A
  • 52 Week Low
  • EXAS $38.81
  • SWKS $47.93
  • 52 Week High
  • EXAS $72.83
  • SWKS $101.50
  • Technical
  • Relative Strength Index (RSI)
  • EXAS 68.53
  • SWKS 48.78
  • Support Level
  • EXAS $52.85
  • SWKS $75.62
  • Resistance Level
  • EXAS $54.74
  • SWKS $78.26
  • Average True Range (ATR)
  • EXAS 1.40
  • SWKS 2.33
  • MACD
  • EXAS 0.17
  • SWKS -0.35
  • Stochastic Oscillator
  • EXAS 93.39
  • SWKS 30.59

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About SWKS Skyworks Solutions Inc.

Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.

Share on Social Networks: